Compare SLQT & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLQT | XBIT |
|---|---|---|
| Founded | 1985 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.4M | 69.8M |
| IPO Year | 2020 | 2015 |
| Metric | SLQT | XBIT |
|---|---|---|
| Price | $0.36 | $1.98 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.09 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 65.1K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,618,499,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.88 | $30.47 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.02 | N/A |
| 52 Week Low | $0.30 | $1.81 |
| 52 Week High | $2.17 | $3.44 |
| Indicator | SLQT | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 45.07 |
| Support Level | N/A | N/A |
| Resistance Level | $0.78 | $2.42 |
| Average True Range (ATR) | 0.02 | 0.12 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 94.17 | 43.40 |
SelectQuote Inc is a technology-enabled, direct-to-consumer (DTC) distribution and engagement platform for selling insurance policies and healthcare services. Its insurance distribution business allows consumers to transparently and conveniently shop for senior health, life, and automobile and home insurance policies from a curated panel of the nation's insurance carriers. It operates in three reportable segments: Senior, Healthcare Services, and Life. Senior sells senior Medicare-related health insurance products. Healthcare Services includes SelectRx, Healthcare Select, and SPM. Healthcare Services provides products and services to its Medicare policyholders, which are focused on improving patient health outcomes. Life sells term life and final expense products.
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.